Pioglitazone Hydrochloride And Metformin Hydrochloride Tablet, Film Coated
Pricing Report NDC 57237-218-81

Latest NADAC: $0.58772 per EA · Effective Feb 19, 2020 · Est. package price $105.79 (180 EA)

Current Package Pricing Information

The latest wholesale acquisition cost for Pioglitazone Hydrochloride And Metformin Hydrochloride (NDC 57237-218-81) is $0.58772 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Feb 19, 2020.

As a a human prescription drug provided by Rising Pharma Holdings, Inc., this medication is distributed in a 180 TABLET, FILM COATED in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.58772
Per EA

Effective Date
Feb 19, 2020
Billable Units
180 EA
Estimated Package Price
$105.79
Data Status
As of Feb 19, 2020
C/I - Chain or Independent Pharmacy
Package NDC
Description
180 TABLET, FILM COATED in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Oct 2016, the NADAC wholesale price for (NDC ) has moved within a range of $0.21803 to $1.75833 per EA. Over this 9 years and 10 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.2180 - $1.7583
Market Volatility
706.46% Variance
Latest Trend
9.37%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $0.27504 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jul 22, 2026 $0.30349 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jun 17, 2026 $0.29317 EAC/I - Chain or Independent PharmacyCode 1G - Generic
May 20, 2026 $0.28136 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Apr 22, 2026 $0.27840 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Mar 18, 2026 $0.28154 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Feb 18, 2026 $0.28228 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jan 21, 2026 $0.29900 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Dec 17, 2025 $0.29332 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Nov 19, 2025 $0.28574 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Oct 22, 2025 $0.28819 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Sep 17, 2025 $0.27916 EAC/I - Chain or Independent PharmacyCode 1G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026